Kura Oncology, Inc. KURA
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Etzer Darout |
Barclays |
11.17 $ |
28 $ |
16.83 % |
24/11/2025 |
| Joseph Pantginis |
H.C. Wainwright |
11.78 $ |
40 $ |
28.22 % |
14/11/2025 |
| Bradley Canino |
Stifel Nicolaus |
10.8 $ |
11 $ |
0.20 % |
22/11/2024 |
| David Dai |
UBS |
17.02 $ |
27 $ |
9.98 % |
24/10/2024 |
| Bradley Canino |
Stifel Nicolaus |
18.58 $ |
19 $ |
0.42 % |
14/10/2024 |
| Joseph Pantginis |
H.C. Wainwright |
21.08 $ |
32 $ |
10.92 % |
25/06/2024 |
| Bradley Canino |
Stifel Nicolaus |
21.43 $ |
28 $ |
6.57 % |
23/05/2024 |
| Mara Goldstein |
Mizuho Securities |
13.81 $ |
26 $ |
12.19 % |
22/12/2023 |